Ads
related to: plaque psoriasis injection treatment- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Psoriasis Symptoms
Learn More Information About
The Symptoms of Plaque Psoriasis.
- Side Effects
What You Need To Know
About Benefits and Side Effects
- See Real Patient Stories
Hear From Real Patients
And View Treatment Options.
- Dosage Information
Learn about Dosage Information
For How to Take Treatment
- Patient Stories
Watch Videos of Real Psoriasis
Patients Sharing Their Stories.
- Before & After Photos
Search results
Results From The WOW.Com Content Network
Tildrakizumab was approved by the Food and Drug Administration in March 2018, [2] and the European Medicines Agency in September 2018, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy. [2] [3] Tildrakizumab is administered via subcutaneous injection.
Risankizumab, sold under the brand name Skyrizi (/ s k aɪ ˈ r ɪ z i / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. [6] [7] It is designed to target interleukin 23A (IL-23A). [6] [7] [9] It is given by subcutaneous injection. [6] [7]
For premium support please call: 800-290-4726 more ways to reach us
Bimekizumab, sold under the brand name Bimzelx (/ b ɪ m ˈ z ɛ l ɪ k s / bim-ZEL-iks), is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody [6] [7] that is used to treat plaque psoriasis, psoriatic arthritis, axial spondyloarthritis, ankylosing spondylitis, and hidradenitis suppurativa.
In July 2017, the US Food and Drug Administration (FDA) approved guselkumab for the treatment of plaque psoriasis. [16] In November 2017, Health Canada approved guselkumab for the treatment of plaque psoriasis. [17] In September 2020, the approval was expanded to include the treatment of adults with psoriatic arthritis. [18]
Ustekinumab is used to treat psoriasis. [29] This includes psoriatic arthritis when it affects the skin. [31] [29] It is indicated for the treatment of adult and adolescent patients (12 years and older) with moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapy, and adults with active psoriatic arthritis (PsA) alone or in combination with methotrexate.
Ads
related to: plaque psoriasis injection treatment